Hepatocellular carcinoma patients with undetectable baseline hepatitis B viral DNA may benefit from immunotherapy
Abstract Background The relationship between hepatitis B virus (HBV) load and the survival or safety of immunotherapy in patients with advanced hepatocellular carcinoma (HCC) remains ambiguous. Methods A multicenter study involving patients with advanced HCC who are treated with anti-PD-1 immunother...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | BMC Gastroenterology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12876-025-04043-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|